Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3424934012 | Bezlotoxumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3424935013 | Bezlotoxumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 759711000241117 | bezlotoxumab (substance) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 794851000172111 | bezlotoxumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bezlotoxumab (substance) | est un(e) (attribut) | Monoclonal immunoglobulin G (substance) | true | Inferred relationship | Some | ||
| Bezlotoxumab (substance) | est un(e) (attribut) | Immunoglobulin IgG1 (substance) | false | Inferred relationship | Some | ||
| Bezlotoxumab (substance) | est un(e) (attribut) | Monoclonal antibody (substance) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only bezlotoxumab (medicinal product) | a pour principe actif (attribut) | True | Bezlotoxumab (substance) | Inferred relationship | Some | 1 |
| Product containing only bezlotoxumab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Bezlotoxumab (substance) | Inferred relationship | Some | 1 |
| Product containing bezlotoxumab (medicinal product) | a pour principe actif (attribut) | True | Bezlotoxumab (substance) | Inferred relationship | Some | 1 |
| Product containing bezlotoxumab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Bezlotoxumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR